{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:27:56Z","timestamp":1779917276901,"version":"3.53.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00393-012-0982-z","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T12:39:21Z","timestamp":1352378361000},"page":"745-753","source":"Crossref","is-referenced-by-count":6,"title":["Update Granulomatose mit Polyangiitis (GPA, Wegener-Granulomatose)","Update on granulomatosis with polyangitis (GPA, Wegener\u2019s granulomatosis)"],"prefix":"10.1007","volume":"71","author":[{"given":"J.U.","family":"Holle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Reinhold-Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,10]]},"reference":[{"key":"982_CR1","first-page":"52","volume":"164","author":"Casian","year":"2011","unstructured":"Casian A (2011) Plasma exchange for severe renal vasculitis: long-term follow-up of the MEPEX trial. Clin Exp Immunol 164(Suppl1):52","journal-title":"Clin Exp Immunol"},{"key":"982_CR2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"Lyons","year":"2012","unstructured":"Lyons P, Rayner T, Trivedi S et al (2012) Genetically distinct subsets in AAV. N Engl J Med 367:214\u2013223","journal-title":"N Engl J Med"},{"key":"982_CR3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ard.2010.130971","volume":"70","author":"Arning","year":"2011","unstructured":"Arning L, Holle JU, Harper L et al (2011) Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis? Ann Rheum Dis 70:707\u2013708","journal-title":"Ann Rheum Dis"},{"key":"982_CR4","doi-asserted-by":"crossref","unstructured":"Besada E, Bader L, Nossent H (2011) Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases. Rheumatol Int [Epub ahead of print]","DOI":"10.1007\/s00296-011-2353-5"},{"key":"982_CR5","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/acr.20605","volume":"Res","author":"Clowse","year":"2011","unstructured":"Clowse ME, Copland SC, Hsieh TC et al (2011) Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Care Res (Hoboken) 63:1777\u20131781","journal-title":"Arthritis Care"},{"key":"982_CR6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2796.2008.02060.x","volume":"265","author":"Eriksson","year":"2009","unstructured":"Eriksson P, Jacobsson L, Lindell A et al (2009) Improved outcome in Wegener\u2019s granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts. J Intern Med 265:496\u2013506","journal-title":"J Intern Med"},{"key":"982_CR7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.2011.150714","volume":"70","author":"Falk","year":"2011","unstructured":"Falk RJ, Gross WL, Guillevin L et al (2011) Granulomatosis with polyangiitis (Wegener\u2019s): an alternative name for Wegener\u2019s granulomatosis. Ann Rheum Dis 70:704","journal-title":"Ann Rheum Dis"},{"key":"982_CR8","first-page":"100","volume":"35","author":"Faurschou","year":"2008","unstructured":"Faurschou M, Sorensen IJ, Mellemkjaer L et al (2008) Malignancies in Wegener\u2019s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 35:100\u2013105","journal-title":"J Rheumatol"},{"key":"982_CR9","doi-asserted-by":"crossref","unstructured":"Fujimoto S, Watts RA, Kobayashi S et al (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 50:1916\u20131920","DOI":"10.1093\/rheumatology\/ker205"},{"key":"982_CR10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/ard.2007.077693","volume":"67","author":"Heckmann","year":"2008","unstructured":"Heckmann M, Holle JU, Arning L et al (2008) The Wegener\u2019s granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis 67:972\u2013979","journal-title":"Ann Rheum Dis"},{"key":"982_CR11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard.2010.145250","volume":"70","author":"Heijl","year":"2011","unstructured":"Heijl C, Harper L, Flossmann O et al (2011) Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials. Ann Rheum Dis 70:1415\u20131421","journal-title":"Ann Rheum Dis"},{"key":"982_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL et al (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605\u2013617","journal-title":"Ann Rheum Dis"},{"key":"982_CR13","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","volume":"304","author":"Hiemstra","year":"2010","unstructured":"Hiemstra TF, Walsh M, Mahr A et al (2010) Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 304:2381\u20132388","journal-title":"JAMA"},{"key":"982_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","volume":"71","author":"Holle","year":"2012","unstructured":"Holle JU, Dubrau C, Herlyn K et al (2012) Rituximab for refractory granulomatosis with polyangiitis (Wegener\u2019s granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis 71:327\u2013333","journal-title":"Ann Rheum Dis"},{"key":"982_CR15","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1136\/ard.2010.130203","volume":"69","author":"Holle","year":"2010","unstructured":"Holle JU, Gross WL, Holl-Ulrich K et al (2010) Prospective long-term follow-up of patients with localised Wegener\u2019s granulomatosis: Does it occur as persistent disease stage? Ann Rheum Dis 69:1934\u20131939","journal-title":"Ann Rheum Dis"},{"key":"982_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.27763","volume":"63","author":"Holle","year":"2011","unstructured":"Holle JU, Gross WL, Latza U et al (2011) Improved outcome in 445 patients with Wegener\u2019s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63:257\u2013266","journal-title":"Arthritis Rheum"},{"key":"982_CR17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"Jayne","year":"2000","unstructured":"Jayne DR, Chapel H, Adu D et al (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433\u2013439","journal-title":"QJM"},{"key":"982_CR18","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","volume":"60","author":"Jones","year":"2009","unstructured":"Jones RB, Ferraro AJ, Chaudhry AN et al (2009) A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 60:2156\u20132168","journal-title":"Arthritis Rheum"},{"key":"982_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"982_CR20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","volume":"14","author":"Kain","year":"2008","unstructured":"Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14:1088\u20131096","journal-title":"Nat Med"},{"key":"982_CR21","doi-asserted-by":"crossref","unstructured":"Kesel N, Kohler D, Herich L et al (2012) Cartilage destruction in granulomatosis with polyangiitis (Wegener\u2019s granulomatosis) is mediated by human fibroblasts after transplantation into immunodeficient mice. Am J Pathol","DOI":"10.1016\/j.ajpath.2012.01.021"},{"key":"982_CR22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"Kessenbrock","year":"2009","unstructured":"Kessenbrock K, Krumbholz M, Schonermarck U et al (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15:623\u2013625","journal-title":"Nat Med"},{"key":"982_CR23","doi-asserted-by":"crossref","first-page":"e28626","DOI":"10.1371\/journal.pone.0028626","volume":"7","author":"Little","year":"2012","unstructured":"Little MA, Al-Ani B, Ren S et al (2012) Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PloS one 7:e28626","journal-title":"PloS one"},{"key":"982_CR24","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA et al (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69:1036\u20131043","journal-title":"Ann Rheum Dis"},{"key":"982_CR25","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.27742","volume":"62","author":"Mahr","year":"2010","unstructured":"Mahr AD, Edberg JC, Stone JH et al (2010) Alpha-antitrypsin deficiency-related alleles Z and S and the risk of Wegener\u2019s granulomatosis. Arthritis Rheum 62:3760\u20133767","journal-title":"Arthritis Rheum"},{"key":"982_CR26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.2130","volume":"16","author":"McKinney","year":"2010","unstructured":"McKinney EF, Lyons PA, Carr EJ et al (2010) A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med 16:586\u2013591 (581p following 591)","journal-title":"Nat Med"},{"key":"982_CR27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"key":"982_CR28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","volume":"53","author":"Reinhold-Keller","year":"2005","unstructured":"Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R et al (2005) Stable incidence of primary systemic vasculitides over five years: results from the German Vasculitis Register. Arthritis Rheum 53:93\u201399","journal-title":"Arthritis Rheum"},{"key":"982_CR29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2011030273","volume":"23","author":"Roth","year":"2012","unstructured":"Roth AJ, Brown MC, Smith RN et al (2012) Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol 23:545\u2013555","journal-title":"J Am Soc Nephrol"},{"key":"982_CR30","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/art.21117","volume":"52","author":"Seo","year":"2005","unstructured":"Seo P, Min YI, Holbrook JT et al (2005) Damage caused by Wegener\u2019s granulomatosis and its treatment: prospective data from the Wegener\u2019s Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 52:2168\u20132178","journal-title":"Arthritis Rheum"},{"key":"982_CR31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"982_CR32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/039463200802100317","volume":"21","author":"Stratta","year":"2008","unstructured":"Stratta P, Marcuccio C, Campo A et al (2008) Improvement in relative survival of patients with vasculitis: study of 101 cases compared to the general population. Int J Immunopathol Pharmacol 21:631\u2013642","journal-title":"Int J Immunopathol Pharmacol"},{"key":"982_CR33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/art.30427","volume":"63","author":"Tesfa","year":"2011","unstructured":"Tesfa D, Ajeganova S, Hagglund H et al (2011) Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections. Arthritis Rheum 63:2209\u20132214","journal-title":"Arthritis Rheum"},{"key":"982_CR34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","volume":"57","author":"Walsh","year":"2011","unstructured":"Walsh M, Catapano F, Szpirt W et al (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 57:566\u2013574","journal-title":"Am J Kidney Dis"},{"key":"982_CR35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","volume":"64","author":"Walsh","year":"2012","unstructured":"Walsh M, Flossmann O, Berden A et al (2012) Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 64:542\u2013548","journal-title":"Arthritis Rheum"},{"key":"982_CR36","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","volume":"9","author":"Westman","year":"1998","unstructured":"Westman KW, Bygren PG, Olsson H et al (1998) Relapse rate, renal survival, and cancer morbidity in patients with Wegener\u2019s granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9:842\u2013852","journal-title":"J Am Soc Nephrol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-0982-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-012-0982-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-0982-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T01:28:26Z","timestamp":1643592506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-012-0982-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s00393-012-0982-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}